Two Dundee University mathematicians have been awarded ?160,000 by the Engineering and Physical Sciences Research Council to develop a new breed of "targeted" anti-cancer drugs. Fordyce Davidson and Mark Chaplain will work with biotechnology company Cyclacel Pharmaceuticals Inc.
请先注册再继续
为何要注册？
- 注册是免费的，而且十分便捷
- 注册成功后，您每月可免费阅读3篇文章
- 订阅我们的邮件
已经注册或者是已订阅？
Please or to read this article.